Drugs / MAGNÓLIA NASAL GEL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04670653 | Aug 2022 → Jul 2023 | allergic rhinitis | EMS | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MAGNÓLIA NASAL GEL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04670653 ↗ |
| Route | Intranasal | “Magnólia nasal gel spray” NCT04670653 ↗ |